Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 14.410
Filtrer
1.
Int J Mol Sci ; 25(13)2024 Jul 01.
Article de Anglais | MEDLINE | ID: mdl-39000368

RÉSUMÉ

Selenium is an essential trace element in our diet, crucial for the composition of human selenoproteins, which include 25 genes such as glutathione peroxidases and thioredoxin reductases. The regulation of the selenoproteome primarily hinges on the bioavailability of selenium, either from dietary sources or cell culture media. This selenium-dependent control follows a specific hierarchy, with "housekeeping" selenoproteins maintaining constant expression while "stress-regulated" counterparts respond to selenium level fluctuations. This study investigates the variability in fetal bovine serum (FBS) selenium concentrations among commercial batches and its effects on the expression of specific stress-related cellular selenoproteins. Despite the limitations of our study, which exclusively used HEK293 cells and focused on a subset of selenoproteins, our findings highlight the substantial impact of serum selenium levels on selenoprotein expression, particularly for GPX1 and GPX4. The luciferase reporter assay emerged as a sensitive and precise method for evaluating selenium levels in cell culture environments. While not exhaustive, this analysis provides valuable insights into selenium-mediated selenoprotein regulation, emphasizing the importance of serum composition in cellular responses and offering guidance for researchers in the selenoprotein field.


Sujet(s)
Sélénium , Sélénoprotéines , Sélénium/sang , Sélénium/métabolisme , Humains , Sélénoprotéines/génétique , Sélénoprotéines/métabolisme , Bovins , Animaux , Cellules HEK293 , Glutathione peroxidase/métabolisme , Glutathione peroxidase/génétique , Glutathione Peroxydase GPX1 , Sérum/métabolisme , Sérum/composition chimique , Phospholipid hydroperoxide glutathione peroxidase/métabolisme , Phospholipid hydroperoxide glutathione peroxidase/génétique , Milieux de culture/composition chimique , Régulation de l'expression des gènes/effets des médicaments et des substances chimiques
2.
Clin Biochem ; 130: 110788, 2024 Aug.
Article de Anglais | MEDLINE | ID: mdl-38969053

RÉSUMÉ

Oxidative stress (OS) results from the imbalance between the production of reactive oxygen species and the body's antioxidant mechanisms and is associated with various diseases, including depression. Antioxidants protect cells by neutralizing free radicals and include enzymatic components such as superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPX), glutathione reductase (GR), and glutathione S-transferase (GST). The concentration of these biomarkers can quantify OS. This research aimed to gather available information published in the last ten years about the concentration of enzymatic OS biomarkers in samples from patients with depressive disorders. METHOD: A systematic review was conducted following the PRISMA guidelines, including original scientific articles that evaluated enzymatic OS biomarkers in participants with depressive disorders, using the keywords and boolean operators "superoxide dismutase" OR "catalase" OR "glutathione" AND "depress*" in the databases PubMed, SAGE Journals, DOAJ, Scielo, Dialnet, and Redalyc. RESULTS: The initial search showed 614 results, with only 28 articles meeting the selection criteria. It was observed that all evaluated oxidative stress enzymatic markers showed a significant increase or decrease in patients with depressive disorders, due to a wide variability in the depressive disorders studied, the type of biological sample analyzed, and the techniques used. CONCLUSION: There is evidence of the relationship between enzymatic OS biomarkers and depressive disorders, but additional studies are needed to clarify the nature of this relationship, particularly considering the different types of depressive disorders.


Sujet(s)
Marqueurs biologiques , Trouble dépressif , Stress oxydatif , Humains , Antioxydants/métabolisme , Marqueurs biologiques/métabolisme , Catalase/métabolisme , Catalase/sang , Trouble dépressif/métabolisme , Glutathione peroxidase/métabolisme , Glutathione reductase/métabolisme , Glutathione transferase/métabolisme , Superoxide dismutase/métabolisme
3.
Cell Mol Biol Lett ; 29(1): 98, 2024 Jul 08.
Article de Anglais | MEDLINE | ID: mdl-38977956

RÉSUMÉ

Phospholipid Hydroperoxide Gluthatione Peroxidase also called Glutathione Peroxidase 4 is one of the 25 described human selenoproteins. It plays an essential role in eliminating toxic lipid hydroxy peroxides, thus inhibiting ferroptosis and favoring cell survival. GPX4 is differentially expressed according to myeloid differentiation stage, exhibiting lower expression in hematopoietic stem cells and polymorphonuclear leucocytes, while harboring higher level of expression in common myeloid progenitors and monocytes. In addition, GPX4 is highly expressed in most of acute myeloid leukemia (AML) subtypes compared to normal hematopoietic stem cells. High GPX4 expression is consistently correlated to poor prognosis in patients suffering AML. However, the role of GPX4 in the development of the myeloid lineage and in the initiation and progression of myeloid leukemia remains poorly explored. Given its essential role in the detoxification of lipid hydroperoxides, and its overexpression in most of myeloid malignancies, GPX4 inhibition has emerged as a promising therapeutic strategy to specifically trigger ferroptosis and eradicate myeloid leukemia cells. In this review, we describe the most recent advances concerning the role of GPX4 and, more generally ferroptosis in the myeloid lineage and in the emergence of AML. We also discuss the therapeutic interest and limitations of GPX4 inhibition alone or in combination with other drugs as innovative therapies to treat AML patients.


Sujet(s)
Ferroptose , Leucémie aigüe myéloïde , Phospholipid hydroperoxide glutathione peroxidase , Humains , Leucémie aigüe myéloïde/anatomopathologie , Leucémie aigüe myéloïde/génétique , Leucémie aigüe myéloïde/métabolisme , Phospholipid hydroperoxide glutathione peroxidase/métabolisme , Phospholipid hydroperoxide glutathione peroxidase/génétique , Ferroptose/génétique , Lignage cellulaire/génétique , Animaux , Cellules myéloïdes/métabolisme , Cellules myéloïdes/anatomopathologie , Glutathione peroxidase/métabolisme , Glutathione peroxidase/génétique
4.
Sci Rep ; 14(1): 16427, 2024 Jul 16.
Article de Anglais | MEDLINE | ID: mdl-39013912

RÉSUMÉ

The ecotoxicological consequences of azoxystrobin on land snails have not yet been addressed. Therefore, the present study aims to provide novel data on the threat of a commercial grade azoxystrobin (AMISTAR) at two environmentally relevant concentrations (0.3 µg/ml) and tenfold (3 µg/ml) on the model species, Theba pisana by physiological, biochemical, and histopathological markers for 28 days. Our results showed a reduction in animal food consumption and growth due to exposure to both azoxystrobin concentrations. It also induced oxidative stress and led to a significant decrease in lipid peroxidation (LPO) levels after 7 days of exposure, while the opposite effect occurred after 28 days. Except for the 7-day exposure, all treated snails had significantly reduced glutathione (GSH) content and increased catalase (CAT) activity at all-time intervals. Glutathione peroxidase (GPx), glutathione-S-transferase (GST) activities, and protein content (PC) were elevated in treated snails at all-time intervals. Moreover, alterations in acetylcholinesterase (AChE) activity between a decrease and an increase were noticed. Additionally, azoxystrobin exerted changes in T. pisana hepatopancreas architecture. Our study suggests that azoxystrobin may have negative ecological consequences for T. pisana and highlights its potential risks to the natural environment.


Sujet(s)
Fongicides industriels , Glutathion , Méthacrylates , Stress oxydatif , Pyrimidines , Escargots , Strobilurines , Animaux , Strobilurines/toxicité , Pyrimidines/toxicité , Stress oxydatif/effets des médicaments et des substances chimiques , Fongicides industriels/toxicité , Méthacrylates/toxicité , Escargots/effets des médicaments et des substances chimiques , Escargots/métabolisme , Glutathion/métabolisme , Peroxydation lipidique/effets des médicaments et des substances chimiques , Glutathione transferase/métabolisme , Acetylcholinesterase/métabolisme , Écotoxicologie , Catalase/métabolisme , Glutathione peroxidase/métabolisme
5.
Pancreas ; 53(7): e588-e594, 2024 Aug 01.
Article de Anglais | MEDLINE | ID: mdl-38986079

RÉSUMÉ

OBJECTIVE: It was targeted to assess the efficacy of certolizumab on pancreas and target organs via biochemical parameters and histopathologic scores in experimental acute pancreatitis (AP). MATERIALS AND METHODS: Forty male Sprague Dawley rats were divided into the following 5 equal groups: group 1 (sham group), group 2 (AP group), group 3 (AP + low-dose certolizumab group), group 4 (AP + high-dose certolizumab group), and group 5 (placebo group). Rats in all groups were sacrificed 24 hours after the last injection and amylase, tumor necrosis factor α, transforming growth factor ß, interleukin 1ß, malondialdehyde, superoxide dismutase, and glutathione peroxidase levels were studied in blood samples. Histopathological investigation of both the pancreas and target organs (lungs, liver, heart, kidneys) was performed by a pathologist blind to the groups. In silico analysis were also accomplished. RESULTS: The biochemical results in the certolizumab treatment groups were identified to be significantly favorable compared to the AP group (P < 0.001). The difference between the high-dose group (group 4) and low-dose treatment group (group 3) was found to be significant in terms of biochemical parameters and histopathological scores (P < 0.001). In terms of the effect of certolizumab treatment on the target organs (especially on lung tissue), the differences between the low-dose treatment group (group 3) and high-dose treatment group (group 4) with the AP group (group 2) were significant. CONCLUSIONS: Certolizumab has favorable protective effects on pancreas and target organs in AP. It may be a beneficial agent for AP treatment and may prevent target organ damage.


Sujet(s)
Amylases , Poumon , Pancréas , Pancréatite , Rat Sprague-Dawley , Facteur de nécrose tumorale alpha , Animaux , Mâle , Pancréatite/prévention et contrôle , Pancréatite/induit chimiquement , Pancréatite/anatomopathologie , Pancréatite/traitement médicamenteux , Pancréas/effets des médicaments et des substances chimiques , Pancréas/anatomopathologie , Pancréas/métabolisme , Amylases/sang , Maladie aigüe , Poumon/effets des médicaments et des substances chimiques , Poumon/anatomopathologie , Poumon/métabolisme , Facteur de nécrose tumorale alpha/métabolisme , Facteur de nécrose tumorale alpha/sang , Certolizumab pégol/pharmacologie , Malonaldéhyde/métabolisme , Foie/effets des médicaments et des substances chimiques , Foie/anatomopathologie , Foie/métabolisme , Rein/effets des médicaments et des substances chimiques , Rein/anatomopathologie , Rein/métabolisme , Interleukine-1 bêta/sang , Interleukine-1 bêta/métabolisme , Superoxide dismutase/métabolisme , Glutathione peroxidase/métabolisme , Myocarde/anatomopathologie , Myocarde/métabolisme , Facteur de croissance transformant bêta/métabolisme , Rats , Modèles animaux de maladie humaine , Stress oxydatif/effets des médicaments et des substances chimiques
6.
Clin Biochem ; 130: 110790, 2024 Aug.
Article de Anglais | MEDLINE | ID: mdl-38969054

RÉSUMÉ

This study aims to investigate the alteration of salivary biomarker profiling in the development of oral submucous fibrosis (OSMF) and to explore the influence of saliva in the diagnosis of OSMF. A systematic search of published articles using the PRISMA guidelines was conducted to identify relevant studies on OSMF and saliva. All eligible studies, including case-control, cross-sectional studies, cohort, and pilot studies, contained the evaluation of salivary biomarker profiling in patients with OSMF. Salivary biomarker data from 28 selected articles were categorized into nine groups, and their mean values were determined. A three-step meta-analysis was performed by grouping salivary biomarker profiling into more heterogeneous categories based on OSMF classification, considering functional, histological, and clinical grading. The salivary biomarker profiling analysis revealed significant alterations in all markers, indicating their efficacy in OSMF diagnosis. Subgroup analyses highlighted significant associations in oxidative stress and protein with increased mean values, particularly emphasizing lipid peroxidase (LPO), malondialdehyde (MDA), and lactate dehydrogenase (LDH). Conversely, decreased mean values were observed in glutathione, glutathione peroxidase (GPx), superoxide dismutase (SOD), and vitamins. Notably, OSMF grading analysis demonstrated a significant difference in weighted effect sizes for histological grading, particularly in stage IV. The study underscores the alteration of specific salivary biomarkers, particularly those associated with LPO, MDA, LDH, glutathione, GPx, SOD, and vitamins, in diagnosing and grading OSMF.


Sujet(s)
Marqueurs biologiques , Glutathione peroxidase , Malonaldéhyde , Fibrose buccale sous-muqueuse , Salive , Superoxide dismutase , Humains , Marqueurs biologiques/métabolisme , Glutathion/métabolisme , Glutathione peroxidase/métabolisme , L-Lactate dehydrogenase/métabolisme , Malonaldéhyde/métabolisme , Fibrose buccale sous-muqueuse/métabolisme , Fibrose buccale sous-muqueuse/anatomopathologie , Fibrose buccale sous-muqueuse/diagnostic , Stress oxydatif , Salive/métabolisme , Superoxide dismutase/métabolisme , Vitamines
7.
Planta ; 260(2): 51, 2024 Jul 12.
Article de Anglais | MEDLINE | ID: mdl-38995415

RÉSUMÉ

MAIN CONCLUSION: Reactive nitrogen species mitigate the deteriorative effect of accelerated seed ageing by affecting the glutathione concentration and activities of GR and GPX-like. The treatment of apple (Malus domestica Borkh.) embryos isolated from accelerated aged seeds with nitric oxide-derived compounds increases their vigour and is linked to the alleviation of the negative effect of excessive oxidation processes. Reduced form of glutathione (GSH) is involved in the maintenance of redox potential. Glutathione peroxidase-like (GPX-like) uses GSH and converts it to oxidised form (GSSG), while glutathione reductase (GR) reduces GSSG into GSH. The aim of this work was to investigate the impact of the short-time NOx treatment of embryos isolated from apple seeds subjected to accelerated ageing on glutathione-related parameters. Apple seeds were subjected to accelerated ageing for 7, 14 or 21 days. Isolated embryos were shortly treated with NOx and cultured for 48 h. During ageing, in the axes of apple embryos, GSH and GSSG levels as well as half-cell reduction potential remained stable, while GR and GPX-like activities decreased. However, the positive effect of NOx in the vigour preservation of embryos isolated from prolonged aged seeds is linked to the increased total glutathione pool, and above all, higher GSH content. Moreover, NOx increased the level of transcripts encoding GPX-like and stimulated enzymatic activity. The obtained results indicate that high seed vigour related to the mode of action of NO and its derivatives is closely linked to the maintenance of higher GSH levels.


Sujet(s)
Glutathion , Malus , Graines , Malus/génétique , Malus/métabolisme , Graines/métabolisme , Graines/génétique , Glutathion/métabolisme , Espèces réactives de l'azote/métabolisme , Glutathione reductase/métabolisme , Glutathione reductase/génétique , Glutathione peroxidase/métabolisme , Glutathione peroxidase/génétique , Oxydoréduction , Monoxyde d'azote/métabolisme , Régulation de l'expression des gènes végétaux
8.
Zhong Nan Da Xue Xue Bao Yi Xue Ban ; 49(4): 553-561, 2024 Apr 28.
Article de Anglais, Chinois | MEDLINE | ID: mdl-39019784

RÉSUMÉ

OBJECTIVES: Age-related cataract is the most common type of adult cataract and a leading cause of blindness. Currently, there are few reports on the establishment of animal models for age-related cataract. During the experimental breeding of Microtus fortis (M. fortis), we first observed that M. fortis aged 12 to 15 months could naturally develop cataracts. This study aims to explore the possibility of developing them as an animal model for age-related cataract via identifing and analyzing spontaneous cataract in M. fortis. METHODS: The 12-month-old healthy M. fortis were served as a control group and 12-month-old cataractous M. fortis were served as an experimental group. The lens transparency was observed using the slit-lamp biomicroscope. Hematoxylin and eosin staining was used to detect pathological changes in the lens. Biochemical detection methods were applied to detect blood routine, blood glucose levels, the serum activities of superoxide dismutase (SOD), and glutathione peroxidase (GSH-Px) in both groups. Finally, real-time RT-PCR was used to detect the transcription levels of cataract-related genes in the lens of 2 groups. RESULTS: Compared with the control group, the lens of cataract M. fortis showed severely visible opacity, the structure of lens was destroyed seriously, and some pathological damage, such as swelling, degeneration/necrosis, calcification, hyperplasia, and fiber liquefaction were found in lens epithelial cells (LECs). The fibrous structure was disorganized and irregularly distributed with morgagnian globules (MGs) aggregated in the degenerated lens fibers. There was no statistically significant difference in blood glucose levels between the experimental and control groups (P>0.05). However, white blood cell (WBC) count (P<0.05), lymphocyte count (P<0.01), and lymphocyte ratio (P<0.05) were significantly decreased, while neutrophil percentage (P<0.05) and monocyte ratio (P<0.01) were significantly increased. The serum activities of SOD and GSH-Px (both P<0.05) were both reduced. The mRNAs of cataract-related genes, including CRYAA, CRYBA1, CRYBB3, Bsfp1, GJA3, CRYBA2, MIP, HspB1, DNase2B, and GJA8, were significantly downregultaed in the lenses of the experimental group (all P<0.05). CONCLUSIONS: There are significant differences in lens pathological changes, peroxidase levels, and cataract-related gene expression between cataract and healthy M. fortis. The developed cataract spontaneously in M. fortis is closely related to age, the cataract M. fortis might be an ideal animal model for the research of age-related cataract.


Sujet(s)
Arvicolinae , Cataracte , Glutathione peroxidase , Cristallin , Superoxide dismutase , Animaux , Cataracte/génétique , Cataracte/anatomopathologie , Cataracte/étiologie , Cristallin/anatomopathologie , Glutathione peroxidase/génétique , Glutathione peroxidase/métabolisme , Glutathione peroxidase/sang , Superoxide dismutase/génétique , Superoxide dismutase/métabolisme , Vieillissement , Modèles animaux de maladie humaine
9.
Nutrients ; 16(12)2024 Jun 18.
Article de Anglais | MEDLINE | ID: mdl-38931278

RÉSUMÉ

Corn peptide (CP) is a short, naturally occurring, and physiologically active peptide generated from corn-protease-catalyzed hydrolysis. CP plays a role in preventing obesity-related disorders, but its impact on reducing inflammation is unknown. Hence, this study examined the possible protective effects of corn peptide powder (CPP) against the harmful effects of lipopolysaccharide (LPS), with a particular emphasis on reducing oxidative damage and inflammation in adipocytes. Hence, mature 3T3-L1 adipocytes underwent exposure to 10 ng/mL LPS, with or without CPP (10 and 20 µg/mL). LPS stimulation increased reactive oxygen species and superoxide anion generation. However, this effect was reduced in a dose-dependent manner by pretreatment with CPP. CPP treatment elevated the mRNA expressions of the antioxidant enzymes manganese superoxide dismutase (mnSOD) and glutathione peroxidase 1 (Gpx1) while reducing the mRNA expressions of the cytosolic reactive oxygen species indicators p40 and p67 (NADPH oxidase 2). In addition, CPP inhibited the monocyte chemoattractant protein-1, tumor necrosis factor-alpha, Toll-like receptor 4, and nuclear factor kappa B mRNA expressions induced by LPS. These findings demonstrate that CPP may ameliorate adipocyte dysfunction by suppressing oxidative damage and inflammatory responses through a new mechanism known as Toll-like receptor 4/nuclear factor kappa B-mediated signaling.


Sujet(s)
Cellules 3T3-L1 , Adipocytes , Inflammation , Lipopolysaccharides , Stress oxydatif , Espèces réactives de l'oxygène , Superoxide dismutase , Récepteur de type Toll-4 , Zea mays , Animaux , Souris , Adipocytes/effets des médicaments et des substances chimiques , Adipocytes/métabolisme , Zea mays/composition chimique , Espèces réactives de l'oxygène/métabolisme , Inflammation/métabolisme , Récepteur de type Toll-4/métabolisme , Stress oxydatif/effets des médicaments et des substances chimiques , Superoxide dismutase/métabolisme , Poudres , Peptides/pharmacologie , Glutathione peroxidase/métabolisme , Facteur de transcription NF-kappa B/métabolisme , Antioxydants/pharmacologie , Glutathione Peroxydase GPX1 , Transduction du signal/effets des médicaments et des substances chimiques , Chimiokine CCL2/métabolisme , Chimiokine CCL2/génétique , Facteur de nécrose tumorale alpha/métabolisme , Anti-inflammatoires/pharmacologie
10.
Cells ; 13(11)2024 Jun 05.
Article de Anglais | MEDLINE | ID: mdl-38891117

RÉSUMÉ

Fibroblast growth factor 5 (FGF5) plays key roles in promoting the transition from the anagen to catagen during the hair follicle cycle. The sheep serves as an excellent model for studying hair growth and is frequently utilized in various research processes related to human skin diseases. We used the CRISPR/Cas9 system to generate four FGF5-edited Dorper sheep and only low levels of FGF5 were detected in the edited sheep. The density of fine wool in GE sheep was markedly increased, and the proportion of fine wool with a diameter of 14.4-20.0 µm was significantly higher. The proliferation signal in the skin of gene-edited (GE) sheep was stronger than in wild-type (WT) sheep. FGF5 editing decreased cortisol concentration in the skin, further activated the activity of antioxidant enzymes such as Glutathione peroxidase (GSH-Px), and regulated the expression of Wnt signaling pathways containing Wnt agonists (Rspondins, Rspos) and antagonists (Notum) in hair regeneration. We suggest that FGF5 not only mediates the activation of antioxidant pathways by cortisol, which constitutes a highly coordinated microenvironment in hair follicle cells, but also influences key signals of the Wnt pathway to regulate secondary hair follicle (SHF) development. Overall, our findings here demonstrate that FGF5 plays a significant role in regulating SHF growth in sheep and potentially serves as a molecular marker of fine wool growth in sheep breeding.


Sujet(s)
Facteur de croissance fibroblastique de type 5 , Glutathione peroxidase , Follicule pileux , Voie de signalisation Wnt , Laine , Animaux , Facteur de croissance fibroblastique de type 5/métabolisme , Facteur de croissance fibroblastique de type 5/génétique , Ovis , Laine/métabolisme , Follicule pileux/métabolisme , Follicule pileux/croissance et développement , Glutathione peroxidase/métabolisme , Glutathione peroxidase/génétique , Édition de gène , Hydrocortisone/métabolisme , Prolifération cellulaire , Systèmes CRISPR-Cas/génétique
11.
J Med Food ; 27(6): 533-544, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38836511

RÉSUMÉ

Valproic acid is an effective treatment for generalized seizure and related neurological defects. Despite its efficacy and acceptability, its use is associated with adverse drug effects. Moringa oleifera leaves are rich in phytochemical and nutritional components. It has excellent antioxidant and ethnobotanical benefits, thus popular among folk medicines and nutraceuticals. In the present study, 70% ethanol extract of moringa leaves was assessed for its in vivo biochemical and histological effects against valproate-induced kidney damage. Female Sprague-Dawley rats were randomly divided into four groups: Group I: control animals given physiological saline (n = 8); Group II: Moringa extract-administered group (0.3 g/kg b.w./day, n = 8); Group III: valproate-administered animals (0.5 g/kg b.w./day, n = 15); and Group IV: valproate + moringa extract (given similar doses of both valproate and moringa extract, n = 12) administered group. Treatments were administered orally for 15 days, the animals were fasted overnight, anesthetized, and then tissue samples harvested. In the valproate-administered experimental group, serum urea and uric acid were elevated. In the kidney tissue of the valproate rats, glutathione was depleted, antioxidant enzyme activities (superoxide dismutase, catalase, glutathione reductase, glutathione S-transferase, and glutathione peroxidase) disrupted, while oxidative stress biomarker, inflammatory proteins (Tumor necrosis factor-alpha and interleukin-6), histological damage scores, and the number of PCNA-positive cells were elevated. M. oleifera attenuated all these biochemical defects through its plethora of diverse antioxidant and therapeutic properties.


Sujet(s)
Antioxydants , Rein , Moringa oleifera , Stress oxydatif , Extraits de plantes , Rat Sprague-Dawley , Acide valproïque , Animaux , Moringa oleifera/composition chimique , Acide valproïque/effets indésirables , Extraits de plantes/pharmacologie , Extraits de plantes/administration et posologie , Femelle , Rats , Rein/effets des médicaments et des substances chimiques , Rein/métabolisme , Rein/anatomopathologie , Stress oxydatif/effets des médicaments et des substances chimiques , Antioxydants/pharmacologie , Superoxide dismutase/métabolisme , Maladies du rein/induit chimiquement , Maladies du rein/traitement médicamenteux , Maladies du rein/métabolisme , Feuilles de plante/composition chimique , Glutathion/métabolisme , Facteur de nécrose tumorale alpha/métabolisme , Humains , Interleukine-6/métabolisme , Interleukine-6/génétique , Catalase/métabolisme , Glutathione peroxidase/métabolisme
12.
Sci Prog ; 107(2): 368504241257128, 2024.
Article de Anglais | MEDLINE | ID: mdl-38860303

RÉSUMÉ

The primary objective of this trial was to study the effects of stress caused by stocking density in tilapia (Oreochromis niloticus) cultured in the in-pond raceway system (IPRS). Fingerlings (Initial body weight = 30.00 ± 1.20 g) were reared at different stocking densities i.e. low stocking density (n = 13,000; 1.77 kg/m3), medium stocking density (MSD) (n = 17,000; 2.32 kg/m3), and high stocking density (HSD) (n = 21,000; 2.86 kg/m3), all confined within the raceways of the IPRS. Each group was studied in triplicates. The observed growth revealed a regression in the HSD treatment, evident in its reduced weight gain per fish per day, in contrast to other treatments. Survival rate across all treatments was above 99%. Notably, the HSD treatment exhibited an elevated level of cortisol; however, this intensified crowding stress did not significantly undermine the nutritional value of the fish in HSD and other experimental treatments. Furthermore, an elevation in the levels of superoxide dismutase, catalase, and glutathione peroxidase was noted within the HSD treatment in comparison to the other treatments to reduce the damage caused by reactive oxygen species. As the trial proceeded, functions of digestive enzymes like amylase, protease, and lipase diminished consistently across all treatments. This could possibly signify a deliberate redirection of energy resources toward stress alleviation rather than the usual digestive processes. In summation, it can be reasonably deduced that a stocking density of approximately 2.32 kg/m3 (MSD) emerges as the optimal threshold for effectively cultivating tilapia within an intensive aquaculture framework.


Sujet(s)
Aquaculture , Tilapia , Animaux , Aquaculture/méthodes , Tilapia/croissance et développement , Tilapia/physiologie , Densité de population , Cichlides/croissance et développement , Cichlides/physiologie , Stress physiologique , Glutathione peroxidase/métabolisme , Hydrocortisone/métabolisme , Catalase/métabolisme , Superoxide dismutase/métabolisme
13.
Biomolecules ; 14(6)2024 Jun 13.
Article de Anglais | MEDLINE | ID: mdl-38927092

RÉSUMÉ

Reactive oxygen species (ROSs) are byproducts of normal cellular metabolism and play pivotal roles in various physiological processes. Disruptions in the balance between ROS levels and the body's antioxidant defenses can lead to the development of numerous diseases. Glutathione peroxidase 3 (GPX3), a key component of the body's antioxidant system, is an oxidoreductase enzyme. GPX3 mitigates oxidative damage by catalyzing the conversion of hydrogen peroxide into water. Beyond its antioxidant function, GPX3 is vital in regulating metabolism, modulating cell growth, inducing apoptosis and facilitating signal transduction. It also serves as a significant tumor suppressor in various cancers. Recent studies have revealed aberrant expression of GPX3 in several non-neoplastic diseases, associating it with multiple pathological processes. This review synthesizes the current understanding of GPX3 expression and regulation, highlighting its extensive roles in noncancerous diseases. Additionally, this paper evaluates the potential of GPX3 as a diagnostic biomarker and explores emerging therapeutic strategies targeting this enzyme, offering potential avenues for future clinical treatment of non-neoplastic conditions.


Sujet(s)
Glutathione peroxidase , Humains , Glutathione peroxidase/métabolisme , Glutathione peroxidase/génétique , Espèces réactives de l'oxygène/métabolisme , Stress oxydatif , Animaux , Antioxydants/métabolisme , Maladies non transmissibles
14.
J Ethnopharmacol ; 333: 118483, 2024 Oct 28.
Article de Anglais | MEDLINE | ID: mdl-38914150

RÉSUMÉ

ETHNOPHARMACOLOGICAL RELEVANCE: Acetaminophen (APAP) induced liver injury (AILI) is a common cause of clinical hepatic damage and even acute liver failure. Our previous research has shown that Schisandra chinensis lignan extract (SLE) can exert a hepatoprotective effect by regulating lipid metabolism. Although polysaccharides from Schisandra chinensis (S. chinensis), like lignans, are important components of S. chinensis, their pharmacological activity and target effects on AILI have not yet been explored. AIM OF THE STUDY: This study aims to quantitatively reveal the role of SCP in the pharmacological activity of S. chinensis, and further explore the pharmacological components, potential action targets and mechanisms of S. chinensis in treating AILI. MATERIALS AND METHODS: The therapeutic effect of SCP on AILI was systematically determined via comparing the efficacy of SCP and SLE on in vitro and in vivo models. Network pharmacology, molecular docking and multi-omics techniques were then used to screen and verify the action targets of S. chinensis against AILI. RESULTS: SCP intervention could significantly improve AILI, and the therapeutic effect was comparable to that of SLE. Notably, the combination of SCP and SLE did not produce mutual antagonistic effects. Subsequently, we found that both SCP and SLE could significantly reverse the down-regulation of GPX4 caused by the APAP modeling, and then further improving lipid metabolism abnormalities. CONCLUSIONS: Hepatoprotective effects of SCP and SLE is most correlated with their regulation of GSH/GPX4-mediated lipid accumulation. This is the first exploration of the hepatoprotective effect and potential mechanism of SCP in treating AILI, which is crucial for fully utilizing S. chinensis and developing promising AILI therapeutic agents.


Sujet(s)
Glutathion , Lignanes , Métabolisme lipidique , Polyosides , Schisandra , Lignanes/pharmacologie , Schisandra/composition chimique , Polyosides/pharmacologie , Animaux , Métabolisme lipidique/effets des médicaments et des substances chimiques , Glutathion/métabolisme , Lésions hépatiques dues aux substances/traitement médicamenteux , Lésions hépatiques dues aux substances/métabolisme , Lésions hépatiques dues aux substances/prévention et contrôle , Simulation de docking moléculaire , Acétaminophène , Glutathione peroxidase/métabolisme , Humains , Mâle , Souris , Extraits de plantes/pharmacologie
15.
Metab Brain Dis ; 39(5): 953-966, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38869783

RÉSUMÉ

Monosodium glutamate (MSG) is the sodium compound derived from glutamic acid. Excessive daily ingestion of MSG leads to elevated amounts of glutamic acid in the bloodstream, which can be detrimental to brain structures. Camellia sinensis, often known as green tea (GT), is a rich source of essential hexogen antioxidants that are necessary for the body. Thirty-two adult male albino rats were divided into four groups (n = 8). Group 1 served as a control -ve group. Group 2 was given GT (1.5 ml/rat/day). Group 3 was given MSG (600 mg/kg/day). Group 4 was given MSG (600 mg/kg/day) and GT (1.5 ml/rat/day). All treatments were given orally for 28 days. MSG administration resulted in significant neurotoxicity in rats that was revealed by the significant reduction of serum concentration of glutathione peroxidase (GPx) and nitric oxide (NO), and the significant elevation of total antioxidant capacity (TAC) accompanied by the significant reduction of levels of serum monoamines (dopamine, serotonin, and norepinephrine) and histological changes in the hippocampus area CA1, dentate gyrus, and cerebellar cortex and positive immunohistochemical staining of glial fibrillary acidic proteins (GFAP) and calretinin. Administration of GT with MSG counteracted the MSG-mediated oxidative stress by significantly increasing serum concentrations of GPX and NO and significantly decreasing concentrations of TAC. Furthermore, GT significantly increased levels of serum monoamines (dopamine, serotonin, and norepinephrine). Moreover, it ameliorated the histological changes, GFAP, and calretinin immunostaining in brain tissues. It is envisaged that GT will serve as a viable protective choice for the inclusion of the neurotoxicity treatment procedure.


Sujet(s)
Antioxydants , Camellia sinensis , Syndromes neurotoxiques , Glutamate de sodium , Animaux , Glutamate de sodium/toxicité , Mâle , Camellia sinensis/composition chimique , Rats , Syndromes neurotoxiques/prévention et contrôle , Syndromes neurotoxiques/traitement médicamenteux , Antioxydants/pharmacologie , Encéphale/effets des médicaments et des substances chimiques , Encéphale/métabolisme , Encéphale/anatomopathologie , Neuroprotecteurs/pharmacologie , Neuroprotecteurs/usage thérapeutique , Stress oxydatif/effets des médicaments et des substances chimiques , Extraits de plantes/pharmacologie , Extraits de plantes/usage thérapeutique , Glutathione peroxidase/métabolisme , Monoxyde d'azote/métabolisme , Rat Wistar
16.
J Cancer Res Clin Oncol ; 150(6): 324, 2024 Jun 25.
Article de Anglais | MEDLINE | ID: mdl-38914724

RÉSUMÉ

OBJECTIVES: Cholangiocarcinoma (CCA) is a rare tumor with a poor prognosis and poses significant therapeutic challenges. Herein, we investigated the mechanism of efficacy of 125I seed implantation therapy in CCA, focusing on the induction of reactive oxygen species (ROS)-mediated apoptosis and the involvement of glutathione peroxidase 2 (GPX2). MATERIALS AND METHODS: Human cholangiocarcinoma cell lines QBC939 and RBE were purchased for in vitro studies. In vivo studies were performed using a rabbit VX2 CCA model. Apoptosis and proliferation were detected by TUNEL staining and clone formation, respectively. ROS generation was detected by dihydroethidium staining. Histological evaluation was performed by hematoxylin and eosin staining. Protein expression was determined by Western blotting and immunohistochemistry. RESULTS: Our results demonstrate that 125I seeds effectively inhibited tumor growth in the rabbit VX2 tumor model and promoted the apoptosis of CCA cells in vitro in a dose-dependent manner. Molecular analyses indicate a marked increase in reactive oxygen species (ROS) levels following treatment with 125I seeds, suggesting the involvement of ROS-mediated apoptosis in the therapeutic mechanism. Furthermore, the downregulation of glutathione peroxidase 2 (GPX2) was observed, indicating its potential role in modulating ROS-mediated apoptosis in CCA. CONCLUSION: 125I seed implantation therapy exerts therapeutic effects on CCA by inducing ROS-mediated apoptosis. The downregulation of GPX2 may contribute to enhanced ROS accumulation and apoptotic cell death. These findings provide mechanistic insights into the therapeutic potential of 125I seed implantation for CCA and highlight ROS-mediated apoptosis and GPX2 regulation as promising targets for further investigation and therapeutic intervention in this malignancy.


Sujet(s)
Apoptose , Tumeurs des canaux biliaires , Cholangiocarcinome , Glutathione peroxidase , Radio-isotopes de l'iode , Espèces réactives de l'oxygène , Cholangiocarcinome/anatomopathologie , Cholangiocarcinome/métabolisme , Cholangiocarcinome/radiothérapie , Cholangiocarcinome/thérapie , Radio-isotopes de l'iode/usage thérapeutique , Animaux , Espèces réactives de l'oxygène/métabolisme , Glutathione peroxidase/métabolisme , Humains , Tumeurs des canaux biliaires/anatomopathologie , Tumeurs des canaux biliaires/métabolisme , Tumeurs des canaux biliaires/radiothérapie , Tumeurs des canaux biliaires/thérapie , Lapins , Lignée cellulaire tumorale , Prolifération cellulaire , Tests d'activité antitumorale sur modèle de xénogreffe
17.
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue ; 36(5): 491-495, 2024 May.
Article de Chinois | MEDLINE | ID: mdl-38845495

RÉSUMÉ

OBJECTIVE: To investigate the effect of nuclear factor E2-related factor 2 (Nrf2) protein on ferroptosis in mice with sepsis-associated liver injury (SALI). METHODS: he male Sprague-Dawley (SD) mice were divided into 6 groups according to the random number table method, with 6 mice in each group. The SALI model of mice was established by cecal ligation and puncture (CLP), and the Sham group was only treated with laparotomy. CLP+Fer-1 group, CLP+Erastin group, CLP+ML385 group and CLP+Curcumin group were intraperitoneally injected with iron death inhibitor Ferrostatin-1 (Fer-1) 10 mg×kg-1×d-1, iron death activator Erastin 20 mg×kg-1×d-1, Nrf2 inhibitor ML385 30 mg×kg-1×d-1 and Nrf2 activator Curcumin 100 mg×kg-1×d-1 after CLP, respectively; Sham group and CLP group were given normal saline 10 mg×kg-1×d-1, each group was administered continuously for 10 days. Ten days after operation, the serum and liver tissues of mice were collected to detect the levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in serum, and the levels of malondialdehyde (MDA), glutathione (GSH) and Fe2+; in liver homogenate. The pathological changes of liver tissue were observed under light microscope after hematoxylin-eosin (HE) staining. The shape and length of mitochondria in liver cells were observed under transmission electron microscope. The protein expressions of Nrf2, glutathione peroxidase 4 (GPX4) and prostaglandin-endoperoxide synthase 2 (PTGS2) in liver tissue were detected by Western blotting. RESULTS: Compared with Sham group, the serum levels of ALT and AST in the CLP group were significantly increased; histologically, the hepatic cord was disordered, the cells were swollen and necrotic, and the length of mitochondria was significantly shortened; the levels of MDA and Fe2+ in liver tissue increased significantly, and the content of GSH decreased significantly; the protein expressions of Nrf2 and GPX4 in liver tissue decreased, and the protein expression of PTGS2 increased significantly. Compared with CLP group, the serum levels of ALT and AST in CLP+Fer-1 group and CLP+Curcumin group were significantly decreased [ALT (U/L): 80.65±19.44, 103.45±20.52 vs. 283.50±37.12, AST (U/L): 103.33±11.90, 127.33±15.79 vs. 288.67±36.82, all P < 0.05]; microscopically, the hepatic cord was irregular, the cells were slightly swollen, and the mitochondrial length was significantly increased (µm: 1.42±0.09, 1.43±0.21 vs. 1.07±0.25, both P < 0.05); the levels of MDA and Fe2+; in liver tissue decreased significantly, and the content of GSH increased significantly [MDA (mol/g): 0.87±0.23, 1.85±0.43 vs. 4.47±0.95, Fe2+ (µg/g): 63.80±7.15, 67.48±6.28 vs. 134.52±14.32, GSH (mol/g): 1.95±0.29, 1.95±0.45 vs. 0.55±0.29, all P < 0.05]; the protein expressions of Nrf2 and GPX4 in liver tissue were significantly increased, and the protein expression of PTGS2 was significantly decreased (Nrf2/GAPDH: 1.80±0.28, 2.10±0.43 vs. 0.70±0.24, GPX4/GAPDH: 0.80±0.06, 0.93±0.07 vs. 0.48±0.02, PTGS2/GAPDH: 0.76±0.05, 0.84±0.01 vs. 1.02±0.09, all P < 0.05). However, the results of the above indexes in the CLP+Erastin group and CLP+ML385 group were opposite, and the serum levels of ALT and AST were significantly increased [ALT (U/L): 344.52±40.79, 321.70±21.10 vs. 283.50±37.12, AST (U/L): 333.50±27.90, 333.00±16.67 vs. 288.67±36.82, all P < 0.05]; microscopically, the arrangement of hepatic cords was disordered, the cells were obviously swollen and necrotic, and the length of mitochondria was significantly shortened (µm: 0.78±0.13, 0.67±0.07 vs. 1.07±0.25, both P < 0.05); the levels of MDA and Fe2+ in liver tissue increased significantly, and the content of GSH decreased significantly [MDA (mol/g): 5.92±1.06, 5.62±0.56 vs. 4.47±0.95, Fe2+ (µg/g): 151.40±8.03, 151.88±8.68 vs. 134.52±14.32, GSH (mol/g): 0.25±0.08, 0.23±0.11 vs. 0.55±0.29, all P < 0.05]; the protein expressions of Nrf2 and GPX4 in liver tissue were significantly decreased, and the protein expression of PTGS2 was significantly increased (Nrf2/GAPDH: 0.46±0.09, 0.46±0.11 vs. 0.70±0.24, GPX4/GAPDH: 0.34±0.05, 0.40±0.01 vs. 0.48±0.02, PTGS2/GAPDH: 1.24±0.13, 1.16±0.11 vs. 1.02±0.09, all P < 0.05). CONCLUSIONS: CLP-induced SALI can lead to ferroptosis in mice hepatocytes, and Nrf2 protein in liver tissue can mediate SALI by regulating ferroptosis.


Sujet(s)
Ferroptose , Facteur-2 apparenté à NF-E2 , Sepsie , Animaux , Mâle , Souris , Facteur-2 apparenté à NF-E2/métabolisme , Sepsie/métabolisme , Sepsie/complications , Modèles animaux de maladie humaine , Foie/métabolisme , Rat Sprague-Dawley , Maladies du foie/étiologie , Maladies du foie/métabolisme , Glutathione peroxidase/métabolisme , Malonaldéhyde/métabolisme , Curcumine/pharmacologie , Phénylènediamines/pharmacologie , Cyclohexylamines
18.
Clin Exp Dent Res ; 10(3): e907, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38881240

RÉSUMÉ

OBJECTIVE: The present systematic review explored the involvement of enzymatic and nonenzymatic antioxidants in periodontitis, drawing from established literature. MATERIALS AND METHODS: The research approach encompassed an extensive electronic search from 2000 to 2023 across databases such as PubMed, Science Direct, and Wiley Online Library and cross-referencing using specific keywords. RESULTS: The initial literature exploration generated a total of 766 articles. After thoroughly examining the abstracts, 693 articles were excluded from consideration due to duplication and lack of relevance to the central research inquiry. Following that, 73 articles were left for in-depth evaluation. Following a qualitative assessment, 35 studies that satisfied the inclusion criteria were chosen, while 38 were removed for not meeting the necessary standards. Within this selection, a meta-analysis was conducted on 11 articles that provided consistent data for quantitative synthesis. Specifically, the analysis of glutathione (GSH) levels in serum samples revealed a standardized mean difference (SMD) of -5.552 µg/mL (CI 95%: -9.078 to -2.026; P-0.002). In contrast, the analysis of glutathione peroxidase (GPx) enzymes in gingival crevicular fluid (GCF) samples displayed an overall SMD of 2.918 ng/µL (CI 95%: 0.372-5.465; P-0.025), while salivary samples exhibited an overall SMD value of 0.709 U/l (95% CI: -1.907-3.325; P-0.596) which is of insignificant. CONCLUSION: The systematic review findings suggest a notable decrease in antioxidant enzymes across various systemic biological samples among patients with periodontitis, contrasting with the results from gingival tissue samples meta-analysis of GPx enzyme.


Sujet(s)
Glutathione peroxidase , Glutathione reductase , Glutathion , Parodontite , Humains , Parodontite/diagnostic , Parodontite/sang , Parodontite/métabolisme , Glutathione peroxidase/métabolisme , Glutathion/métabolisme , Glutathione reductase/métabolisme , Disulfure de glutathion/métabolisme , Disulfure de glutathion/sang , Exsudat gingival/composition chimique , Antioxydants/métabolisme , Antioxydants/analyse
19.
PLoS One ; 19(6): e0305636, 2024.
Article de Anglais | MEDLINE | ID: mdl-38885232

RÉSUMÉ

Empagliflozin (EMPA) showed antiapoptotic, oxidative and anti-inflammatory potential effect. EMPA attenuates the inflammation and oxidative stress biomarkers in patients with heart failure while significantly decreases the malondialdehyde (a lipid peroxidation marker) levels in the plasma of diabetic patients. The present study examined the effects of moderate hyperglycemia on reproductive function. Sixty male Wister rats were divided and randomly allocated into four groups of 15 animals each . Diabetes was induced by a single intraperitoneal injection of a prepared solution containing STZ diluted in 0.1 M sodium citrate buffer (pH 4.5) at a dosage of 40 mg/kg body weight in selected in groups II and III for seven days before starting the treatment with EMPA. The current study revealed that EMPA for eight weeks prevented testicular high glucose-induced oxidative stress markers such as penile nitric oxide (NO), glutathione peroxidase (GPX) and total anti-oxidant capacity (TAC) in STZ-induced hyperglycemia in a rat model. In addition, EMPA ameliorated the high levels of endogenous Interleukin-6 (IL-6) present in gonads in response to an acute inflammatory found in the hyperglycemic STZ-induced rats. The present study further suggested the protective effects of EMPA and how it has a beneficial role and can effectively attenuate hyperglycemia-induced testicular oxidative damage and inflammatory markers as well as androgen dependent testicular enzymes activity as a protective role against the consequences of hyperglycemia and male sub-infertility.


Sujet(s)
Composés benzhydryliques , Glucosides , Hyperglycémie , Stress oxydatif , Rat Wistar , Testicule , Animaux , Mâle , Composés benzhydryliques/pharmacologie , Glucosides/pharmacologie , Testicule/effets des médicaments et des substances chimiques , Testicule/métabolisme , Rats , Stress oxydatif/effets des médicaments et des substances chimiques , Hyperglycémie/traitement médicamenteux , Hyperglycémie/métabolisme , Diabète expérimental/traitement médicamenteux , Diabète expérimental/métabolisme , Monoxyde d'azote/métabolisme , Interleukine-6/métabolisme , Glycémie/métabolisme , Antioxydants/pharmacologie , Antioxydants/métabolisme , Glutathione peroxidase/métabolisme
20.
Int J Mol Sci ; 25(11)2024 May 23.
Article de Anglais | MEDLINE | ID: mdl-38891864

RÉSUMÉ

According to the World Health Organization (WHO), breast cancer (BC) is the deadliest and the most common type of cancer worldwide in women. Several factors associated with BC exert their effects by modulating the state of stress. They can induce genetic mutations or alterations in cell growth, encouraging neoplastic development and the production of reactive oxygen species (ROS). ROS are able to activate many signal transduction pathways, producing an inflammatory environment that leads to the suppression of programmed cell death and the promotion of tumor proliferation, angiogenesis, and metastasis; these effects promote the development and progression of malignant neoplasms. However, cells have both non-enzymatic and enzymatic antioxidant systems that protect them by neutralizing the harmful effects of ROS. In this sense, antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), glutathione reductase (GR), thioredoxin reductase (TrxR), and peroxiredoxin (Prx) protect the body from diseases caused by oxidative damage. In this review, we will discuss mechanisms through which some enzymatic antioxidants inhibit or promote carcinogenesis, as well as the new therapeutic proposals developed to complement traditional treatments.


Sujet(s)
Antioxydants , Tumeurs du sein , Espèces réactives de l'oxygène , Humains , Antioxydants/métabolisme , Antioxydants/usage thérapeutique , Tumeurs du sein/métabolisme , Tumeurs du sein/traitement médicamenteux , Tumeurs du sein/anatomopathologie , Femelle , Espèces réactives de l'oxygène/métabolisme , Stress oxydatif , Peroxirédoxines/métabolisme , Animaux , Glutathione peroxidase/métabolisme , Catalase/métabolisme , Superoxide dismutase/métabolisme
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...